BioSpace News Archive

After visiting labs around the world to identify ways to advance its industry-leading cell counting technology, Beckman Coulter Life Sciences will host a live streaming event on March 26 at 10 a.m. EDT / 7 a.m. PDT to announce its latest product innovation.

Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Richard C. E. Morgan has tendered his resignation as Non-executive Chairman and is stepping down from the Board of Directors, effective immediately, to focus on other business commitments.

Reston Hospital Center has achieved Comprehensive Center Re-Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP®).

NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary oligonucleotide delivery technology to develop novel agents, today announced that the company has entered into a research collaboration with Astellas Pharma Inc. for the discovery and development of novel oligonucleotide therapeutics.

On January 24, 2019, ZOLL learned of a data security incident that impacted the personal and medical information of some patients.

Perrigo Company plc a leading global provider of “Quality, Affordable, Self-Care Products™" announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Finacea® Foam 15%.

Dr. Reddy’s Laboratories Ltd. announces the launch of its advanced B2B Customer Service Portal “XCEED.”

Mike Turrell, CEO of Ultimate Health Plans, and Jean Arrington, Chief Innovation Officer of HealthMine to co-present ‘High Performing Plan: Can Members Drive the Highest Performing Plan?’

David Cobrinik, MD, PhD, investigates how light-sensing cells of the eye turn cancerous

Emergent Connect, LLC, a provider of cloud-based PACS software, announces it has acquired TouchstoneNet, which specializes in Radiology billing software and Scheduling.